Daratumumab-based regimen for newly diagnosed multiple myeloma patients with paraskeletal plasmacytomas: a retrospective study in a single center
Objective To analyze the efficacy of daratumumab-based regimen in newly diagnosed multiple myeloma(NDMM) patients with paraskeletal plasmacytomas (PPs).Methods The medical data of 28 NDMM patients with PPs were retrospectively analyzed. The daratumumab-based regimen was divided into group A, and the...
Saved in:
Main Authors: | Shuiqing Xu, Wenming Chen, Yanchen Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Hematology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2024.2431958 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bilateral Bulky Adrenal Plasmacytomas with Very Good Response to Daratumumab-Based Therapy
by: Fang-Yu Wang, et al.
Published: (2023-04-01) -
Efficacy of Daratumumab‐Based Regimens for Extramedullary Pulmonary Plasmacytoma: A Case Report
by: Danilo De Novellis, et al.
Published: (2024-11-01) -
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab‐based regimens
by: Danilo De Novellis, et al.
Published: (2024-07-01) -
Is There a Role for Daratumumab Retreatment in Patients with Relapsed/Refractory Multiple Myeloma?
by: Davor Galusic, et al.
Published: (2025-01-01) -
EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?
by: Pellegrino Musto, et al.
Published: (2024-08-01)